78156-13-5

Basic information

• Product Name: (2-morpholin-4-yl-ethyl)-(2-nitro-phenyl)-amine
• Synonyms: (2-morpholin-4-yl-ethyl)-(2-nitro-phenyl)-amine
• CAS NO: 78156-13-5
• Molecular Weight: 251.285
• Mol File: 78156-13-5.mol
• Article Data: 15

Chemical Properties

• CAS DataBase Reference: (2-morpholin-4-yl-ethyl)-(2-nitro-phenyl)-amine(CAS DataBase Reference)
• NIST Chemistry Reference: (2-morpholin-4-yl-ethyl)-(2-nitro-phenyl)-amine(78156-13-5)
• EPA Substance Registry System: (2-morpholin-4-yl-ethyl)-(2-nitro-phenyl)-amine(78156-13-5)

Safety Data

• Hazardous Substances Data: 78156-13-5(Hazardous Substances Data)

Upstream product

• 863012-89-9 (2-aminoethyl)morpholine 
• 88-73-3 2-Chloronitrobenzene 
• 2038-03-1 4-(2-AMINOETHYL)MORPHOLINE 
• 1493-27-2 ortho-nitrofluorobenzene 
• 3240-94-6 N-(2-chlorethyl)morpholine 
• 88-74-4 2-nitro-aniline 

Downstream Products

• 126568-10-3 2-Methyl-1-(2-morpholin-4-yl-ethyl)-1H-benzoimidazole 
• 163618-10-8 N-(3-methyl-1-butyl)-N'-[2-(morpholin-4-yl)ethyl]-1,2-phenylenediamine 
• 163618-11-9 2,4-dioxo-1-(3-methylbutyl)-5-[2-(morpholin-4-yl)ethyl]-3-phenylhydrazono-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine 
• 1222386-18-6 N-{2,4-dioxo-1-(3-methyl-1-butyl)-5-[2-(morpholin-4-yl)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl}-N'-(4-chlorophenyl)urea 
• 1322055-34-4 N-{2,4-dioxo-1-(3-methyl-1-butyl)-5-[2-(morpholin-4-yl)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl}-N'-(3-methylphenyl)urea 
• 1322055-38-8 N-{2,4-dioxo-1-(3-methyl-1-butyl)-5-[2-(morpholin-4-yl)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl}-N'-(4-bromophenyl)urea 
• 1322055-40-2 N-{2,4-dioxo-1-(3-methyl-1-butyl)-5-[2-(morpholin-4-yl)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl}-N'-(4-fluorophenyl)urea 
• 1322055-42-4 N-{2,4-dioxo-1-(3-methyl-1-butyl)-5-[2-(morpholin-4-yl)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl}-N'-(4-ethoxyphenyl)urea 
• 1322055-46-8 N-{2,4-dioxo-1-(3-methyl-1-butyl)-5-[2-(morpholin-4-yl)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl}-N'-[4-bromo-2-methylphenyl]urea 
• 1322055-49-1 N-{2,4-dioxo-1-(3-methyl-1-butyl)-5-[2-(morpholin-4-yl)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl}-N'-[4-methoxy-2-methylphenyl]urea 
• 1322055-51-5 N-{2,4-dioxo-1-(3-methyl-1-butyl)-5-[2-(morpholin-4-yl)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl}-N'-(2-isopropylphenyl)urea 
• 1322055-53-7 N-{2,4-dioxo-1-(3-methyl-1-butyl)-5-[2-(morpholin-4-yl)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl}-N'-[2-chloro-6-methylphenyl]urea 
• 78156-04-4 N-[2-(morpholin-4-yl)ethyl]-1,2-phenylenediamine 

Relevant articles and documents

1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention relates to 1,3,4-oxadiazole derivative compounds having a histone deacetylase 6 (HDAC6) inhibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof, a use thereof in preparation of a medicament, a pharmaceutical composition comprising the same, a therapeutic method using the composition, and a method for preparing the same, and the 1,3,4-oxadiazole derivative compounds are represented by a following chemical formula (I).

Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[ a[phenazin derivatives as dual topoisomerase I/II inhibitors

A novel series of benzo[a]phenazin derivatives bearing alkylamino side chains were designed, synthesized and evaluated for their topoisomerases inhibitory activity as well as cytotoxicity against four human cancer cell lines (HL-60, K-562, HeLa, and A549)

Synthesis and structure-activity relationship of new 1,5-dialkyl-1,5- benzodiazepines as cholecystokinin-2 receptor antagonists

This article deals with the synthesis and the activities of some 1,5-dialkyl-3-arylureido-1,5-benzodiazepin-2,4-diones which were prepared as potential CCK2 antagonists, with the intention to find a possible follow up of our lead compound GV150013, showin